Exploring the molecular basis of action of ring D aromatic steroidal antiestrogens

被引:10
作者
Alvarez, Lautaro D.
Veleiro, Adriana S.
Burton, Gerardo [1 ]
机构
[1] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, RA-1428 Buenos Aires, DF, Argentina
关键词
estrogen receptor; salpichrolide; withanolide; antiestrogenic; molecular dynamics; NUCLEAR RECEPTOR SUPERFAMILY; HUMAN ESTROGEN-RECEPTOR; LIGAND-BINDING DOMAIN; SALPICHROA-ORIGANIFOLIA; DYNAMICS SIMULATIONS; UNBINDING PATHWAYS; WITHANOLIDES; PHYTOESTROGENS; ANTAGONISM; ALPHA;
D O I
10.1002/prot.24820
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Salpichrolides are natural plant steroids that contain an unusual six-membered aromatic ring D. We recently reported that some of these compounds, and certain analogs with a simplified side chain, exhibited antagonist effects toward the human estrogen receptor (ER), a nuclear receptor whose endogenous ligand has an aromatic A ring (estradiol). Drugs acting through the inhibition or modulation of ERs are frequently used as a hormonal therapy for ER(+) breast cancer. Previous results suggested that the aromatic D ring was a key structural motif for the observed activity; thus, this modified steroid nucleus may provide a new scaffold for the design of novel antiestrogens. Using molecular dynamics (MD) simulation we have modeled the binding mode of the natural salpichrolide A and a synthetic analog with an aromatic D ring within the ER. These results taken together with the calculated energetic contributions associated to the different ligand-binding modes are consistent with a preferred inverted orientation of the steroids in the ligand-binding pocket with the aromatic ring D occupying a position similar to that observed for the A ring of estradiol. Major changes in both dynamical behavior and global positioning of H11 caused by the loss of the ligand-His524 interaction might explain, at least in part, the molecular basis of the antagonism exhibited by these compounds. Using steered MD we also found a putative unbinding pathway for the steroidal ligands through a cavity formed by residues in H3, H7, and H11, which requires only minor changes in the overall receptor conformation. Proteins 2015; 83:1297-1306. (c) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:1297 / 1306
页数:10
相关论文
共 39 条
[1]   Quantum Mechanical Binding Free Energy Calculation for Phosphopeptide Inhibitors of the Lck SH2 Domain [J].
Anisimov, Victor M. ;
Cavasotto, Claudio N. .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2011, 32 (10) :2254-2263
[2]  
[Anonymous], 2009, Stewart Computational Chemistry
[3]   Current and Future Development of Estrogen Receptor Ligands: Applications in Estrogen-Related Cancers [J].
Bolli, Alessandro ;
Marino, Maria .
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2011, 5 (03) :210-229
[4]   Structural analysis of nuclear receptors: From isolated domains to integral proteins [J].
Brelivet, Yann ;
Rochel, Natacha ;
Moras, Dino .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 348 (02) :466-473
[5]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[6]   Ligand unbinding from the estrogen receptor: A computational study of pathways and ligand specificity [J].
Burendahl, Sofia ;
Danciulescu, Cristian ;
Nilsson, Lennart .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2009, 77 (04) :842-856
[7]   Unbinding Pathways from the Glucocorticoid Receptor Shed Light on the Reduced Sensitivity of Glucocorticoid Ligands to a Naturally Occurring, Clinically Relevant Mutant Receptor [J].
Capelli, Anna Maria ;
Bruno, Agostino ;
Entrena Guadix, Antonio ;
Costantino, Gabriele .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (17) :7003-7014
[8]  
Case DA., 2014, AMBER14
[9]  
Cassidy Aedin, 2003, J Br Menopause Soc, V9, P17, DOI 10.1258/136218003100322099
[10]   Phytoestrogens and bone health at different reproductive stages [J].
Castelo-Branco, Camil ;
Soveral, Iris .
GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (08) :735-743